These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7908243)

  • 1. Clinical development of anticancer agents from natural products.
    Parkinson DR; Arbuck SG; Moore T; Pluda JM; Christian MC
    Stem Cells; 1994 Jan; 12(1):30-43. PubMed ID: 7908243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy.
    Cragg GM; Newman DJ
    J Nat Prod; 2004 Feb; 67(2):232-44. PubMed ID: 14987065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
    Jung LL; Zamboni WC
    Drug Resist Updat; 2001 Aug; 4(4):273-88. PubMed ID: 11998845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
    Garcia-Carbonero R; Supko JG
    Clin Cancer Res; 2002 Mar; 8(3):641-61. PubMed ID: 11895891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anticancer agents: taxol, camptothecin analogs, and anthrapyrazoles.
    Hawkins MJ
    Oncology (Williston Park); 1992 Dec; 6(12):17-23; discussion 27-30. PubMed ID: 1361358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
    Jung LL; Zamboni WC
    Drug Resist Updat; 2001 Jun; 4(3):152-67. PubMed ID: 11768329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Camptothecin and derivatives: a new class of antitumor agents].
    Torck M; Pinkas M
    J Pharm Belg; 1996; 51(4):200-7. PubMed ID: 8965250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCdelta-GFP.
    Baryza JL; Brenner SE; Craske ML; Meyer T; Wender PA
    Chem Biol; 2004 Sep; 11(9):1261-7. PubMed ID: 15380186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents.
    Altmann KH; Gertsch J
    Nat Prod Rep; 2007 Apr; 24(2):327-57. PubMed ID: 17390000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
    Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxic activity of new 9-substituted camptothecins.
    Dallavalle S; Rocchetta DG; Musso L; Merlini L; Morini G; Penco S; Tinelli S; Beretta GL; Zunino F
    Bioorg Med Chem Lett; 2008 May; 18(9):2781-7. PubMed ID: 18434153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-based anticancer molecules: a chemical and biological profile of some important leads.
    Srivastava V; Negi AS; Kumar JK; Gupta MM; Khanuja SP
    Bioorg Med Chem; 2005 Nov; 13(21):5892-908. PubMed ID: 16129603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpene lactones from Gonospermum gomerae and G. fruticosum and their cytotoxic activities.
    Triana J; Eiroa JL; Ortega JJ; León F; Brouard I; Torres F; Quintana J; Estévez F; Bermejo J
    J Nat Prod; 2008 Dec; 71(12):2015-20. PubMed ID: 19053514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annonaceous acetogenins: recent progress.
    Alali FQ; Liu XX; McLaughlin JL
    J Nat Prod; 1999 Mar; 62(3):504-40. PubMed ID: 10096871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of E-ring modifications in camptothecin on topoisomerase I inhibition: a quantum mechanics treatment.
    Xiao X; Cushman M
    J Org Chem; 2005 Nov; 70(23):9584-7. PubMed ID: 16268636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The medicinal potential of promising marine macrolides with anticancer activity.
    Qi Y; Ma S
    ChemMedChem; 2011 Mar; 6(3):399-409. PubMed ID: 21302362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.